RNA-based therapy in the management of lipid disorders: a review.
Ontology highlight
ABSTRACT: This review focuses on antisense oligonucleotides and small interfering ribonucleic acid therapies approved or under development for the management of lipid disorders. Recent advances in RNA-based therapeutics allow tissue-specific targeting improving safety. Multiple potential target proteins have been identified and RNA-based therapeutics have the potential to significantly improve outcomes for patients with or at risk for atherosclerotic cardiovascular disease. The advantages of RNA-based lipid modifying therapies include the ability to reduce the concentration of almost any target protein highly selectively, allowing for more precise control of metabolic pathways than can often be achieved with small molecule-based drugs. RNA-based lipid modifying therapies also make it possible to red
SUBMITTER: Blom DJ
PROVIDER: S-EPMC9034497 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA